Delivery Order SPE2DE22D0008-SPE2D626F4X04
Award Date 3/24/26
Potential Completion Date 3/27/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,750 delivery order to Alba Bioscience, Inc. on March 12, 2026, for ALBACLONE Anti-C monoclonal antibody reagent, with completion by March 17, 2026. Place of performance is Chicago, IL. Alba Bioscience supplies immunohematology reagents and blood banking diagnostic materials to federal healthcare systems, including monoclonal antibodies, antibody identification and screening panels, quality control kits, and specialized cell...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,194.00 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-D Blend, a monoclonal antibody reagent used in blood banking and immunohematology testing. The contract is structured as a firm fixed-price delivery order with a completion date of January 30, 2026, and was awarded on January 27, 2026. This award carries no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,422.00 delivery order contract to Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in in vitro diagnostic products and blood banking materials. The award, issued on December 12, 2025, with an ultimate completion date of December 17, 2025, is for ALBACLONE Anti-A monoclonal antibodies used in blood typing and immunohematology testing. This firm fixed-price delivery order carries no...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,250 to Alba Bioscience, Inc. on February 2, 2026, for the supply of ALBACLONE Anti-C (BIG C) monoclonal antibodies. The contract is a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, and will be performed at the vendor's facility in Chicago, Illinois. No set-aside designation was used in this competitive procurement. Alba Bioscience, a Chicago-based subsidiary...
- <p>The Defense Logistics Agency's Medical Supply Chain issued a $5,805 delivery order to Alba Bioscience, Inc. on March 13, 2026, for an Albacyte Antibody ID Panel (10-cell) with an ultimate completion date of May 15, 2026.</p> <p>Place of performance is Chicago, IL 60607. The order is firm fixed price with no set-aside designation.</p>
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- Alba Bioscience, Inc., a Chicago-based specialist in immunohematology reagents and blood banking diagnostic products, was awarded a $1,640 delivery order (Contract No. 4570611216) by the Defense Logistics Agency's Medical Supply Chain division on January 23, 2026. The order, designated for ALBACLONE Anti-K monoclonal antibodies, carries a firm fixed price and an ultimate completion date of January 28, 2026, with performance at the company's facility in Chicago, Illinois. This delivery order...
- The Defense Logistics Agency, operating under the Defense or Civilian designation, awarded a delivery order contract (4568409675) to Alba Bioscience, Inc. on June 2, 2025, for the supply of ALBACLONE Anti-K antibodies. The contract represents a firm fixed price delivery order with a ceiling value of $15,944.00 and an ultimate completion date of June 5, 2025. The award was made on a non-set-aside basis, reflecting Alba Bioscience's competitive standing as an established supplier of specialized...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,150 to Alba Bioscience, Inc. for ALBACYTE Antibody Screen (2-Cell) products, with an ultimate completion date of October 9, 2025. Alba Bioscience, a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was selected through a non-set-aside competitive process. The delivery order falls under the company's existing blanket purchase agreements with the Department of Veterans Affairs, which...